Consistent with the results above, analysis from subcutaneous ID8VEGF tumor-bearing mice showed that the combination of TIM-3 and PD-1 inhibitors could enhance the infiltration, proliferation, and anti-tumor immunity of CD8+TILs (Supplementary Fig. 6B, C). This evidence concerns the gene PDCD1 and neoplasm.